These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 34447385)

  • 1. Transient Depletion of Foxp3
    Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
    Front Immunol; 2021; 12():720133. PubMed ID: 34447385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
    Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
    Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Few Foxp3⁺ regulatory T cells are sufficient to protect adult mice from lethal autoimmunity.
    Mayer CT; Ghorbani P; Kühl AA; Stüve P; Hegemann M; Berod L; Gershwin ME; Sparwasser T
    Eur J Immunol; 2014 Oct; 44(10):2990-3002. PubMed ID: 25042334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.
    Christiaansen AF; Boggiatto PM; Varga SM
    J Immunol Methods; 2014 Apr; 406():58-65. PubMed ID: 24642426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of New Onset Type 1 Diabetes by Oral
    Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
    Front Immunol; 2019; 10():320. PubMed ID: 30863412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model.
    Schuster C; Jonas F; Zhao F; Kissler S
    Eur J Immunol; 2018 Jul; 48(7):1211-1216. PubMed ID: 29604048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective ablation of thymic and peripheral Foxp3
    Yilmazer A; Zevla DM; Malmkvist R; Rodríguez CAB; Undurraga P; Kirgin E; Boernert M; Voehringer D; Kershaw O; Schlenner S; Kretschmer K
    Front Immunol; 2023; 14():1298938. PubMed ID: 38164128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo depletion of FoxP3+ Tregs using the DEREG mouse model.
    Lahl K; Sparwasser T
    Methods Mol Biol; 2011; 707():157-72. PubMed ID: 21287334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes.
    Ling Q; Shen L; Zhang W; Qu D; Wang H; Wang B; Liu Y; Lu J; Zhu D; Bi Y
    Mol Med; 2022 Feb; 28(1):18. PubMed ID: 35123388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory CD4
    Kakabadse D; Chen D; Fishman S; Weinstein-Marom H; Davies J; Wen L; Gross G; Wong FS
    Front Immunol; 2024; 15():1463971. PubMed ID: 39351219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.
    D'Alise AM; Auyeung V; Feuerer M; Nishio J; Fontenot J; Benoist C; Mathis D
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19857-62. PubMed ID: 19073938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
    Sgouroudis E; Albanese A; Piccirillo CA
    J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.
    Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C
    Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
    Holohan DR; Van Gool F; Bluestone JA
    PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.
    Kaminitz A; Mizrahi K; Yaniv I; Stein J; Askenasy N
    J Autoimmun; 2010 Sep; 35(2):145-52. PubMed ID: 20638242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes.
    Zhang XX; Qiao YC; Li W; Zou X; Chen YL; Shen J; Liao QY; Zhang QJ; He L; Zhao HL
    Immunol Res; 2018 Feb; 66(1):179-186. PubMed ID: 28983871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.